Literature DB >> 31141808

Prostaglandin E2 Regulates Activation of Mouse Peritoneal Macrophages by Staphylococcus aureus through Toll-Like Receptor 2, Toll-Like Receptor 4, and NLRP3 Inflammasome Signaling.

Jindi Wu1,2, Bo Liu3,4, Wei Mao1,2, Shuang Feng2,5, Yuan Yao6, Fan Bai2, Yuan Shen1,2, Amu Guleng1,2, Bayin Jirigala2, Jinshan Cao1,2.   

Abstract

Prostaglandin E2 (PGE2), an essential endogenous lipid mediator for normal physiological functions, can also act as an inflammatory mediator in pathological conditions. We determined whether Staphylococcus aureus lipoproteins are essential for inducing PGE2 secretion by immune cells and whether pattern recognition receptors mediate this process. PGE2 levels secreted by mouse peritoneal macrophages infected with the S. aureus isogenic mutant, lgt::ermB (Δlgt; deficient in lipoprotein maturation), decreased compared with those from macrophages infected with wild-type (WT) S. aureus. Experiments using toll-like receptors 2 (TLR2)-deficient, TLR4-deficient, and NLRP3-deficient mice indicated that these 3 proteins are involved in macrophage PGE2 secretion in response to S. aureus, and lipoproteins were essential for S. aureus invasion and survival within macrophages. Inhibition of endogenous PGE2 synthesis had no effect on bacterial invasion. Exogenous PGE2 inhibited phagocytosis in the WT S. aureus and its isogenic mutant but increased intracellular killing accompanied by enhanced IL-1β secretion. Our data demonstrate that S. aureus can induce macrophage TLR/mitogen-activated protein kinase/NF-κB signaling and that PGE2 treatment upregulates NLRP3/caspase-1 signaling activation. Thus, macrophage PGE2 secretion after S. aureus infection depends on bacterial lipoprotein maturation and macrophage receptors TLR2, TLR4, and NLRP3. Moreover, exogenous PGE2 regulates S. aureus-induced macrophage activation through TLRs and NLRP3 inflammasome signaling.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  NLRP3; Prostaglandin E2; Staphylococcus aureus; Toll-like receptor 2; Toll-like receptor 4

Mesh:

Substances:

Year:  2019        PMID: 31141808      PMCID: PMC7098297          DOI: 10.1159/000499604

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  48 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation.

Authors:  P Müller; M Müller-Anstett; J Wagener; Q Gao; S Kaesler; M Schaller; T Biedermann; F Götz
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 3.  Staphylococcus aureus: a well-armed pathogen.

Authors:  G L Archer
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 4.  Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence.

Authors:  Minh Thu Nguyen; Friedrich Götz
Journal:  Microbiol Mol Biol Rev       Date:  2016-08-10       Impact factor: 11.056

5.  Activation of COX-2/mPGES-1/PGE2 Cascade via NLRP3 Inflammasome Contributes to Albumin-Induced Proximal Tubule Cell Injury.

Authors:  Yibo Zhuang; Fei Zhao; Jing Liang; Xu Deng; Yue Zhang; Guixia Ding; Aihua Zhang; Zhanjun Jia; Songming Huang
Journal:  Cell Physiol Biochem       Date:  2017-06-19

6.  Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation.

Authors:  Roman Dziarski; Dipika Gupta
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  A one-plate assay for macrophage bactericidal activity.

Authors:  R Peck
Journal:  J Immunol Methods       Date:  1985-09-03       Impact factor: 2.303

8.  Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus.

Authors:  Masahito Hashimoto; Kazuki Tawaratsumida; Hiroyuki Kariya; Ai Kiyohara; Yasuo Suda; Fumiko Krikae; Teruo Kirikae; Friedrich Götz
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

9.  A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome.

Authors:  Raúl Muñoz-Planillo; Luigi Franchi; Lloyd S Miller; Gabriel Núñez
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

Review 10.  Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases.

Authors:  Jean Y Park; Michael H Pillinger; Steven B Abramson
Journal:  Clin Immunol       Date:  2006-03-15       Impact factor: 3.969

View more
  9 in total

1.  Hederacoside-C Inhibition of Staphylococcus aureus-Induced Mastitis via TLR2 & TLR4 and Their Downstream Signaling NF-κB and MAPKs Pathways In Vivo and In Vitro.

Authors:  Muhammad Akhtar; Aftab Shaukat; Arshad Zahoor; Yu Chen; Ying Wang; Mei Yang; Talha Umar; Mengyao Guo; Ganzhen Deng
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

2.  Serious, Severe, Sepsis.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2020-01-31       Impact factor: 7.349

3.  Toxic Shock Syndrome Toxin 1 Induces Immune Response via the Activation of NLRP3 Inflammasome.

Authors:  Lianci Peng; Jiali Jiang; Tingting Chen; Dongyi Xu; Fengqing Hou; Qingyuan Huang; Yuanyi Peng; Chao Ye; Dong-Liang Hu; Rendong Fang
Journal:  Toxins (Basel)       Date:  2021-01-18       Impact factor: 4.546

4.  Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 Inflammasome.

Authors:  Qimei Luo; Qinghua Hu; Qingkun Zheng; Lewei Gong; Lijuan Su; Baojun Ren; Yongle Ju; Zhanjun Jia; Xianrui Dou
Journal:  Front Med (Lausanne)       Date:  2021-05-18

5.  Novel pyrrolopyrimidine derivatives: design, synthesis, molecular docking, molecular simulations and biological evaluations as antioxidant and anti-inflammatory agents.

Authors:  Amira I Sayed; Yara E Mansour; Mohamed A Ali; Omnia Aly; Zainab M Khoder; Ahmed M Said; Samar S Fatahala; Rania H Abd El-Hameed
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

6.  Low-dose mycophenolate mofetil improves survival in a murine model of Staphylococcus aureus sepsis by increasing bacterial clearance and phagocyte function.

Authors:  Fanny Alby-Laurent; Nadia Belaïdouni; Benoit Blanchet; Christophe Rousseau; Jean-François Llitjos; Sylvia Sanquer; Jean-Paul Mira; Frédéric Pène; Julie Toubiana; Jean-Daniel Chiche
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

7.  Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection.

Authors:  Tomoya Suda; Tomoko Hanawa; Mayuko Tanaka; Yasunori Tanji; Kazuhiko Miyanaga; Sanae Hasegawa-Ishii; Ken Shirato; Takako Kizaki; Takeaki Matsuda
Journal:  Sci Rep       Date:  2022-09-19       Impact factor: 4.996

Review 8.  Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response.

Authors:  Clare T Johnson; Heather B Bradshaw
Journal:  Cannabis Cannabinoid Res       Date:  2021-06

9.  A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress.

Authors:  Yan-Feng Zhang; Chen-Chen Sun; Jia-Xi Duan; Hui-Hui Yang; Chen-Yu Zhang; Jian-Bing Xiong; Wen-Jing Zhong; Cheng Zu; Xin-Xin Guan; Hui-Ling Jiang; Bruce D Hammock; Sung Hee Hwang; Yong Zhou; Cha-Xiang Guan
Journal:  Biomed Pharmacother       Date:  2020-02-27       Impact factor: 6.529

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.